Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro.
Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro.
复制标题
DOI:
10.1002/jcp.21777
复制
发表时间:
2009-08
影响因子:
5.6
通讯作者:
Schaller MD
中科院分区:
文献类型:
--
作者:
Chellaiah MA;Schaller MD
PTP–PEST is involved in the regulation of sealing ring formation in osteoclasts. In this article, we have shown a regulatory role for PTP–PEST on dephosphorylation of c-Src at Y527 and phosphorylation at Y418 in the catalytic site. Activation of Src in osteoclasts by over-expression of PTP–PEST resulted in the phosphorylation of cortactin at Y421 and WASP at Y294. Also enhanced as a result, is the interaction of Src, cortactin, and Arp2 with WASP. Moreover, the number of osteoclasts displaying sealing ring and bone resorbing activity was increased in response to PTP–PEST over-expression as compared with control osteoclasts. Cells expressing constitutively active-Src (527YDF) simulate the effects mediated by PTP–PEST. Treatment of osteoclasts with a bisphosphonate alendronate or a potent PTP inhibitor PAO decreased the activity and phosphorylation of Src at Y418 due to reduced dephosphorylation state at Y527. Therefore, Src-mediated phosphorylation of cortactin and WASP as well as the formation of WASP cortactin Arp2 complex and sealing ring were reduced in these osteoclasts. Similar effects were observed in osteoclasts treated with [C1]an Src inhibitor PP2. We have shown that bisphosphonates could modulate the function of osteoclasts by inhibiting downstream signaling mediated by PTP–PEST/Src, in addition to its effect on the inhibition of the post-translational modification of small GTP-binding proteins such as Rab, Rho, and Rac as shown by others. The promising effects of the inhibitors PP2 and PAO on osteoclast function suggest a therapeutic approach for patients with bone metastases and osteoporosis as an alternative to bisphosphonates.
登录
查看更多内容
影响因子:
4.8
作者:
Chellaiah, MA;Soga, N;Hruska, KA
通讯作者:
Hruska, KA
DOI:
10.1083/jcb.148.4.665
发表时间:
2000-02-21
期刊:
The Journal of cell biology
影响因子:
--
作者:
Chellaiah M;Kizer N;Silva M;Alvarez U;Kwiatkowski D;Hruska KA
通讯作者:
Hruska KA
DOI:
10.1084/jem.20030976
发表时间:
2004-01-05
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Badour K;Zhang J;Shi F;Leng Y;Collins M;Siminovitch KA
通讯作者:
Siminovitch KA
影响因子:
20.3
作者:
Calle, Y;Jones, GE;Thrasher, AJ
通讯作者:
Thrasher, AJ
影响因子:
3.3
作者:
Chellaiah, MA;Kizer, N;Hruska, KA
通讯作者:
Hruska, KA